SCHEMBL3018300

SCHEMBL3018300

CCOC(=O)C=Cc1ccc(NC(=O)c2cc([Si](C)(C)C)cc([Si](C)(C)C)c2)cc1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.45
ALDH1A1 P00352 5/20 0.45
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
ITGB3 P05106 2/20 0.42
ITGAV P06756 2/20 0.42
ITGA2B P08514 2/20 0.42
P2RX3 P56373 2/20 0.41
POLB P06746 1/20 0.40
TP53 P04637 2/20 0.39
THRB P10828 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
LMNA P02545 1/20 0.39
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
HPGD P15428 1/20 0.39
ITGB1 P05556 1/20 0.39
ITGB5 P18084 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3018297 1.00 MAPT (0.45) MAPTALDH1A1KMT2AMEN1ITGB3
SCHEMBL3024513 0.88 P2RX3 (0.40) MAPTP2RX3TP53THRBSMN1; SMN2
SCHEMBL3024515 0.88 P2RX3 (0.40) MAPTP2RX3TP53THRBSMN1; SMN2
SCHEMBL3023901 0.85 ITGB3 (0.56) MAPTALDH1A1KMT2AMEN1ITGB3
SCHEMBL3023900 0.85 ITGB3 (0.56) MAPTALDH1A1KMT2AMEN1ITGB3
SCHEMBL3034258 0.84 CA12 (0.51) MAPTALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL3034256 0.84 CA12 (0.51) MAPTALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL3032267 0.76 CA12 (0.40) MAPTALDH1A1KMT2AMEN1ITGB3
SCHEMBL3032266 0.76 CA12 (0.40) MAPTALDH1A1KMT2AMEN1ITGB3
SCHEMBL13014961 0.74 ITGB3 (0.57) MAPTALDH1A1KMT2AMEN1ITGB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7855300-B2 Bis(trimethylsilyl)phenyl compound or salt thereof, and use thereof TAIHO PHARMACEUTICAL CO., LTD. (JP) 2010-12-21 US disclosed
US-20100210591-A1 BIS(TRIMETHYLSILYL)PHENYL COMPOUND OR SALT THEREOF, AND USE THEREOF TAIHO PHARMACEUTICAL CO., LTD. (JP) 2010-08-19 US disclosed
EP-2202235-A1 BIS(TRIMETHYLSILYL)PHENYL COMPOUND OR SALT THEREOF, AND USE THEREOF Taiho Pharmaceutical Co., Ltd. (JP) 2010-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210591-A1 BIS(TRIMETHYLSILYL)PHENYL COMPOUND OR SALT THEREOF, AND USE THEREOF RARA, RARB, RXRA MAPT 4787/4885ALDH1A1 1156/4885KMT2A 327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.